Catalyst Pharmaceutical Inc. — gráfico, cotizaciones y noticias (NASDAQ:CPRX) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Market Capitalization 3.1972 B
Employee 182
Founded 2002
CEO N/A
Website www.catalystpharma.com
Headquarter Delaware, United States
FIGI BBG000GZDC67
Industry Technology

Ingresos totales

Beneficio neto

Beneficio básico por acción

Deuda total

Flujo de caja libre

Efectivo y equivalentes

3.2 B Capitalización de mercado

Ratio precio/beneficio

13.89

Relación precio/flujo de caja

5.04

Noticias

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

RVMD Stock Rallies 41% on Positive Phase III Pancreatic Cancer Data

ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

SNY & REGN's Dupixent Gets EU Approval for Pediatric Use in Urticaria

IBRX Stock Rises 7% on Strong Q1 2026 Preliminary Results

KYMR Set to Earn Milestone Payment as GILD Secures License for KT-200

If You Invested $1000 in Catalyst Pharmaceutical 10 Years Ago, This Is How Much You'd Have Now

ACIU Stock Rallies 16.3% in a Week: Here's What You Need to Know

Recent Price Trend in Catalyst (CPRX) is Your Friend, Here's Why

Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why

Insmed Ends Brinsupri Development in Skin Disease Post Study Failure